Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Fortis Drops plan to...

    Fortis Drops plan to sell stake in RHT Health Trust, RHTTM

    Farhat NasimWritten by Farhat Nasim Published On 2019-06-18T13:57:11+05:30  |  Updated On 18 Jun 2019 1:57 PM IST
    Fortis Drops plan to sell stake in RHT Health Trust, RHTTM

    New Delhi: Country's one of the leading super speciality hospital chain, Fortis Healthcare (FHL) has recently scrapped the plan to sell stakes in RHT Health Trust and RHT Health Trust Manager Pte Ltd (RHTTM). According to media reports, on June 15 Fortis decided to close the bidding and search process to explore the possibility of a sale of interest in RHT Health Trust and RHT Health Trust Manager Pte Ltd (RHTTM).


    However, a couple of months ago FHL had initiated talks with potential buyers to sell its stake in Singapore listed RHT. Medical dialogues had earlier reported that a couple and a month after acquiring the assets of Religare Health Trust (RHT) for Rs 4650 crore, Fortis Healthcare Ltd. (FHL) had initiated talks with potential buyers to sell its stake in Singapore listed RHT. The sale proceeds were likely to be put back into the Fortis business in India in order to make it more successful.


    Prior to this, Fortis had completed the acquisition of RHT Health Trust (RHT) assets and had entered into definitive agreements with RHT to acquire the entire portfolio of assets of the Singapore-listed entity for an enterprise value of Rs 4,650 crore.


    Also Read: Fortis Healthcare to sell stake in Singapore listed Rs 4650 crore RHT Trust


    In an earlier filing to bourses, the company had said its group firm Fortis Healthcare International Ltd had commenced deliberations to explore the sale of interest in RHT and RHTTM.


    “No firm proposal which is commercially viable was received and no agreement (binding or non- binding) has been reached with any of these parties in connection with the Potential Transactions or any other transaction involving RHT and/or RHTTM," FHL said.


    Also Read: Fortis Healthcare to sell stake in Singapore listed Rs 4650 crore RHT Trust




    RHTTM is a subsidiary of the Stellant. Stellant and Fortis Healthcare International Ltd (FHIL) are direct/ indirect wholly-owned subsidiaries of the company, Fortis Healthcare said in a filing to BSE.



    "Pursuant to an open invitation to interested parties to submit proposals in connection with the potential transactions, a process to evaluate proposals was undertaken with professional advisers, and preliminary discussions were held with certain third parties concerning the Potential Transactions", it added.


    "Since the process to explore the potential transaction was inconclusive, it was decided to close the bidding and search process", it further added.


    Fortis has an aggregate interest in 27.82% of the units in RHT, comprising 25.14% held by FHIL and 2.68% held by the trustee-manager, a unit of Stellant. FHIL and Stellant are wholly-owned subsidiaries of FHL.


    Also Read: Fortis Healthcare International to sell entire stake in MSCL
    BSEFHLFHL sharesFortisFortis HealthcareFortis Healthcare LtdFortis potential transactionFortis sharesfortis shares reductionFortis stakesHealthcareNew DelhiRHTRHT Health TrustRHT Health Trust ManageRHT Health Trust ManagerRHTTMStellant
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok